Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02981940 · ClinicalTrials.gov registry record · Phase 2

A Study of Abemaciclib in Recurrent Glioblastoma

A Phase 2 study of Glioblastoma, sponsored by Dana-Farber Cancer Institute.

Active
Registry status
Phase 2
Development phase
45
Enrollment target
7
Study locations

NCT02981940 is a Phase 2 study of Glioblastoma that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 45 participants, below the 109-participant average among 199 other Glioblastoma trials with a reported enrollment target (59% lower). The trial reports 7 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02981940, a Phase 2 study of Glioblastoma, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
45 participants
Enrollment target
7
Study locations

Study Summary

This research study is studying a targeted therapy as a possible treatment for recurrent glioblastoma (GBM). The following intervention will be used in this study: -Abemaciclib

Conditions Studied

Glioblastoma

Interventions

  • DRUG Abemaciclib
  • PROCEDURE Surgery

Study Locations (7)

California

  • University of California Los Angeles - Los Angeles
  • University of California, San Francisco - San Francisco

Massachusetts

  • Massachusetts General Hospital - Boston
  • Dana Farber Cancer Institute - Boston

New York

  • Memorial Sloan-Kettering Cancer Center - New York

Texas

  • UT, M.D. Anderson Cancer Center - Houston

Utah

  • Huntsman Cancer Institute - Salt Lake City

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2017-02-09
Est. Completion 2026-06-30
Phase Phase 2

Sponsor

Dana-Farber Cancer Institute

781 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02981940

The ClinicalTrials.gov registry entry for NCT02981940 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109-participant average among 199 other Glioblastoma trials with a reported enrollment target (59% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glioblastoma appearing as the primary indexed condition, and to 2 interventions - of which Abemaciclib is the first listed.

NCT02981940 reports 7 study locations spanning 5 distinct geographic areas - top geographies include California, Massachusetts, New York.

Frequently Asked Questions

What is clinical trial NCT02981940 about?

NCT02981940 is a clinical study titled "A Study of Abemaciclib in Recurrent Glioblastoma". This research study is studying a targeted therapy as a possible treatment for recurrent glioblastoma (GBM). The following intervention will be used in this study: -Abemaciclib

What is the current status of trial NCT02981940?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2017-02-09. Estimated completion is 2026-06-30.

What conditions does trial NCT02981940 study?

This clinical trial studies the following conditions: Glioblastoma.

What interventions are being tested in trial NCT02981940?

The interventions under investigation include: Abemaciclib (DRUG), Surgery (PROCEDURE).

Who is sponsoring clinical trial NCT02981940?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02981940 being conducted?

This trial has 7 study locations across California, Massachusetts, New York, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Glioblastoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Glioblastoma

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.